Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Wilmington, Delaware
- Most recent report
- 8-K, filed Sep 10, 2026
- Incorporated
- Delaware
- Filings on record
- 389 filings
- On EDGAR
- CIK 1678660
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 24
News 8 of 71
Prospectuses and Registrations 8 of 24
- 424B5 Prospectus supplement for an offering Apr 21, 2026
- 424B5 Prospectus supplement for an offering Mar 12, 2026
- S-8 Registration statement for an employee plan Mar 10, 2026
- S-3 Shelf registration statement Dec 10, 2025
- S-8 Registration statement for an employee plan Mar 10, 2025
- S-3 Shelf registration statement May 30, 2024
- S-3/A Shelf registration statement, amended May 6, 2024
- S-3 Shelf registration statement Feb 16, 2024
Proxies 8 of 14
- DEFA14A Extra proxy material Apr 29, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2026
- DEFA14A Extra proxy material Apr 29, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2025
- PRE 14A Preliminary proxy statement Apr 11, 2025
- DEFA14A Extra proxy material Apr 26, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 26, 2024
- DEFA14A Extra proxy material Apr 28, 2023
Ownership 8 of 216
- SCHEDULE 13G Large holder reported a passive stake Jul 8, 2026
- 4 Insider reported a trade Jun 10, 2026
- 4 Insider reported a trade Jun 10, 2026
- 4 Insider reported a trade Jun 10, 2026
- 4 Insider reported a trade Jun 10, 2026
- 4 Insider reported a trade Jun 10, 2026
- 4 Insider reported a trade Jun 10, 2026
- 4 Insider reported a trade May 4, 2026
Other 8 of 40
- ARS Annual report sent to shareholders Apr 29, 2026
- EFFECT Notice that a registration became effective Dec 16, 2025
- CORRESP Reply to SEC staff Dec 15, 2025
- ARS Annual report sent to shareholders Apr 29, 2025
- EFFECT Notice that a registration became effective Jun 10, 2024
- CORRESP Reply to SEC staff Jun 6, 2024
- UPLOAD Comment letter from SEC staff Jun 3, 2024
- EFFECT Notice that a registration became effective May 8, 2024
Everything here comes from Prelude Therapeutics Inc's own filings on SEC EDGAR. The filing list is rechecked every hour.